Welcome to Targanta Therapeutics Printer Friendly Version

Greg Moeck, Ph.D.
Director, Biology

Dr. Moeck joined Targanta Therapeutics in 2000 and has served as Director, Biology since February 2005. He currently oversees the characterization of internally-developed compounds using in vitro, cell-based and in vivo assays. Dr. Moeck played a key role in the implementation of Targanta's assay development group and high-throughput screening facility. He received his Ph.D. in Microbiology and Immunology from McGill University in Montreal, Canada and conducted postdoctoral research on bacterial nutrient uptake in Orsay, France.